FDA approval opens new chapter in pancreatic cancer treatment

For decades, a diagnosis of metastatic pancreatic cancer left patients and physicians facing the same harsh reality: limited options, difficult treatments and too little time. Now, a pill tested in a global clinical trial ...

Study tracks early adoption of liver histotripsy treatment

It has been nearly three years since the U.S. Food and Drug Administration (FDA) cleared the HistoSonics Edison histotripsy system to treat primary and metastatic liver tumors. To examine how the technology's adoption and ...

Injury adds hurdles for inactive women in sport

Injury or pain affects participation for one in five physically inactive women taking part in social sport, with those from lower-income households more likely to be injury-affected, new research from La Trobe University ...

page 19 from 40